References
- Noble BA, Loh RS, MacLennan S, Pesudovs K, Reynolds A, Bridges LR, et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004;88:647–652
- Chen YM, Hu FR, Huang JY, Shen EP, Tsai TY, Chen WL. The effect of topical autologous serum on graft re-epithelialization after penetrating keratoplasty. Am J Ophthalmol 2010;150:352–359.e2
- Urzua CA, Vasquez DH, Huidobro A, Hernandez H, Alfaro J. Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome. Curr Eye Res 2012;37:684–688
- Geerling G, Hartwig D. Autologous serum eye drops for ocular surface disorders. Cornea External Eye Dis 2006;20:1–20
- Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I, et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999;83:390–395
- Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115–1120
- Quinto GG, Campos M, Behrens A. Autologous serum for ocular surface diseases. Arq Bras Oftalmol 2008;71:47–54
- Rosenthal RA, Buck SL, Henry CL, Schlech BA. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system. J Ocul Pharmacol Ther 2006;22:440–448
- Rauz S, Saw VP. Serum eye drops, amniotic membrane and limbal epithelial stem cells–tools in the treatment of ocular surface disease. Cell Tissue Bank 2010;11:13–27
- Stack RR, McKellar MJ. Black eye drop bottle tips improve compliance. Clin Experiment Ophthalmol 2004;32:39–41
- Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008;85:668–674
- Kircher W. [Pharmaceutical aids in gerontopharmacology]. Internist (Berl) 2013;54:110–117
- Hahn SR. Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology 2009;116:S37–S42
- Uhlig T, Kvien TK, Jensen JL, Axell T. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis 1999;58:415–422
- Kasper K, Godenschweger L, Hartwig D, Unterlauft JD, Seitz B, Geerling G. [On the use of autologous serum eyedrops in Germany: results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)]. Ophthalmologe 2008;105:644–649
- Choi JA, Chung SH. Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects. Eye Contact Lens 2011;37:370–373
- Geerling G, Grus F, Seitz B, Hartwig D, Schirra F. [Legal regulations to produce serum eye drops: when is it necessary, and how can it be obtained?]. Ophthalmologe 2008;105:632–638
- Dietlein TS, Jordan JF, Luke C, Schild A, Dinslage S, Krieglstein GK. Self-application of single-use eyedrop containers in an elderly population: comparisons with standard eyedrop bottle and with younger patients. Acta Ophthalmol 2008;86:856–859
- Dotan I, Somin M, Basevitz A, Beilinson N, Bardenstein R, Zimhony O, et al. Pathogenic bacteria on personal handbags of hospital staff [letter]. J Hosp Infect 2009;72:90–92
- Mac Donald EC, Lockington D, Roberts F, Tetley L, Ramaesh K. Unit-dose dispenser tips: a potential source of ocular injury [letter]. Br J Ophthalmol 2010;94:136–137
- Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 2011;118:2398–2402
- Van Santvliet L, Ludwig A. Dispensing eye drops from flexible plastic dropper bottles. Part II: Influence of the physico-chemical properties of the formulation and the manipulation technique by the patient. Pharmazeutische Industrie 1999;61:194–198
- Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477–480
- Hennessy AL, Katz J, Covert D, Protzko C, Robin AL. Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss. Ophthalmology 2010;117:2345–2352
- Novack GD, O'Donnell MJ, Molloy DW. New glaucoma medications in the geriatric population: efficacy and safety. J Am Geriatr Soc 2002;50:956–962
- Burns E, Mulley GP. Practical problems with eye-drops among elderly ophthalmology outpatients. Age Ageing 1992;21:168–170
- German EJ, Hurst MA, Wood D. Reliability of drop size from multi-dose eye drop bottles: is it cause for concern? Eye (Lond) 1999;13:93–100
- Dietrich T, Weisbach V, Seitz B, Jacobi C, Kruse FE, Eckstein R, et al. [Manufacture of autologous serum eye drops for out-patient therapy: cooperation between ophthalmic clinic and transfusion medicine department]. Ophthalmologe 2008;105:1036, 1040–100
- Enzenauer RW, Kao A, Williams T, Lambert RW. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions. Eye Contact Lens 2003;29:238–240
- Oldham GB, Andrews V. Control of microbial contamination in unpreserved eyedrops. Br J Ophthalmol 1996;80:588–591
- Kim MS, Choi CY, Kim JM, Chang HR, Woo HY. Microbial contamination of multiply used preservative-free artificial tears packed in reclosable containers. Br J Ophthalmol 2008;92:1518–1521
- Kahook MY. Developments in dosing aids and adherence devices for glaucoma therapy: current and future perspectives. Expert Rev Med Devices 2007;4:261–266
- Corlett AJ. Aids to compliance with medication. BMJ 1996;313:926–929